These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 14671028

  • 21. [New approaches for the treatment of dyslipidemia].
    Mostaza JM, Lahoz C.
    Med Clin (Barc); 2014 Apr 07; 142(7):306-9. PubMed ID: 23768860
    [Abstract] [Full Text] [Related]

  • 22. Beyond statins: what to expect from add-on lipid regulating therapy?
    Laufs U, Weintraub WS, Packard CJ.
    Eur Heart J; 2013 Sep 07; 34(34):2660-5. PubMed ID: 23832488
    [No Abstract] [Full Text] [Related]

  • 23. [Diabetes mellitus and hyperlipidemia].
    Uchida N, Shuto Y, Oikawa S.
    Nihon Rinsho; 2001 Mar 07; 59 Suppl 3():733-7. PubMed ID: 11347163
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Pleiotrophic effect of anti-hyperlipemic agents].
    Morishita R.
    Nihon Naika Gakkai Zasshi; 2001 Oct 10; 90(10):2017-22. PubMed ID: 11769493
    [No Abstract] [Full Text] [Related]

  • 26. Non-adherence to lipid-lowering therapies: a need for more studies to evaluate reasons for medication non-adherence.
    Wong MC, Wang HH, Liu KS.
    Int J Clin Pract; 2011 Dec 10; 65(12):1321-2. PubMed ID: 22093540
    [No Abstract] [Full Text] [Related]

  • 27. Dementia and statins.
    Cheung BM, Kumana CR.
    Lancet; 2001 Mar 17; 357(9259):880; author reply 880-1. PubMed ID: 11265972
    [No Abstract] [Full Text] [Related]

  • 28. Bezafibrate. An update of its pharmacology and use in the management of dyslipidaemia.
    Goa KL, Barradell LB, Plosker GL.
    Drugs; 1996 Nov 17; 52(5):725-53. PubMed ID: 9118820
    [Abstract] [Full Text] [Related]

  • 29. [Drug combination therapies for patients with hyperlipidemia and its significance].
    Onuma T, Kawamori R.
    Nihon Rinsho; 2001 Mar 17; 59 Suppl 3():566-71. PubMed ID: 11347133
    [No Abstract] [Full Text] [Related]

  • 30. Use of lipid-lowering agents (statins) during pregnancy.
    Hosokawa A, Bar-Oz B, Ito S.
    Can Fam Physician; 2003 Jun 17; 49():747-9. PubMed ID: 12836860
    [Abstract] [Full Text] [Related]

  • 31. Lipid-lowering drugs.
    Milander MM, Kuhn M.
    AACN Clin Issues Crit Care Nurs; 1992 May 17; 3(2):494-506. PubMed ID: 1576043
    [Abstract] [Full Text] [Related]

  • 32. Dementia and statins.
    Lowe G, Rumley A, Packard C, Shepherd J.
    Lancet; 2001 Mar 17; 357(9259):881. PubMed ID: 11265975
    [No Abstract] [Full Text] [Related]

  • 33. A practical approach to lipid management in the elderly.
    Viljoen A.
    J Nutr Health Aging; 2011 Jan 17; 15(1):65-70. PubMed ID: 21267522
    [Abstract] [Full Text] [Related]

  • 34. Lipid lowering drugs.
    O'Connor P, Feely J, Shepherd J.
    BMJ; 1990 Mar 10; 300(6725):667-72. PubMed ID: 2182155
    [No Abstract] [Full Text] [Related]

  • 35. Statin utilization patterns for the primary prevention of cardiovascular events: a retrospective study in patients with diabetes mellitus in Hong Kong.
    Lee VW, Ho IC, Chan WS, Tam KY, Lee KK.
    Am J Cardiovasc Drugs; 2008 Mar 10; 8(3):199-205. PubMed ID: 18533740
    [Abstract] [Full Text] [Related]

  • 36. Dementia and statins.
    Kast RE.
    Lancet; 2001 Mar 17; 357(9259):881. PubMed ID: 11265974
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Triglyceride levels, pancreatitis and choice of lipid-modifying therapy.
    Preiss D.
    Expert Rev Gastroenterol Hepatol; 2013 Mar 17; 7(3):193-5. PubMed ID: 23445227
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.